Giardiasis: a pharmacotherapy review

Bibliography

• LANE S, LLOYD D: Current trends in research into the waterborne parasite Giardia. Crit. Rev. Microbiol. (2002) 28:123-147.
   PubMed Web of Science ®Google Scholar
• MANDELL GL, DOUGLAS RG, BENNETT JE, DOLIN R (Eds): Principles and Practice of Infectious Diseases (4th Edn). New York, Edinburgh, London, Madrid, Melbourne, Milan, Tokyo: Churchill Livingston (1995).
   Google Scholar
• GONÇALVES MLC, ARAUJO A, DA SILVA JP, REINHARD K, BOUCHET F, FERREIRA LF: Detection of Giardia doudenalis antigen in coprolites using a commercially available enzyme immunoassay. Trans. R. Soc. Trop. Med. Hyg. (2002) 96:640-643.
   Google Scholar
• DOBELL C: The discovery of the intestinal protozoa of man. Proc. R. Soc. Med. (1920) 13:1-15.
   PubMedGoogle Scholar
• LAMBL W: Mikroskopiche untersuchungen der darmexcrete. Beitrag zur pathologisches des darmes und diagnostik am krankenbette. Viert. Prakst. Prakst. Heilkd. (Prague) (1859) 61:1-57.
   Google Scholar
• BRODSKY RE, SPENCER HC Jr, SCHULTZ MG: Giardiasis in American travelers to the Soviet Union. J. Infect. Dis. (1974) 130:319-323.
   PubMed Web of Science ®Google Scholar
• KETTIS AA, MAGNIUS LG: Giardia lamblia infection in a group of students after a visit to Leningrad in March 1970. Scand. J. Infect. Dis. (1973) 5:289-292.
   PubMed Web of Science ®Google Scholar
• WHO EXPERT COMMITTEE: Intestinal protozoan and helminthic infections. WHO Tech. Rep. Ser. (1981) 58:666-671.
   Google Scholar
• NSTC: Infectious disease – a global health (report of the National Science and Technology Council on emerging and re-emerging infectious diseases), Office of Science and Technology Policy, Washington, DC, USA (1995).
   Google Scholar
• LEVI DA, BENS MS, CRAUN GF, CALDERON RL, HERWALDT BL: Surveillance for waterborne-disease-United States, 1995 – 1996. MMWR Morb. Mort. Weekly Rep. (1998) 47:6-7.
   Google Scholar
• LECLERC H, SCHWARTZBROD L, DEI-CAS E: Microbial agents associated with waterborne diseases. Crit. Rev. Microbiol. (2002) 28:371-409.
   PubMed Web of Science ®Google Scholar
• POZIO E: Foodborne and waterborne parasites. Acta Microbiol. Pol. (2003) 53(Suppl.):83-96.
   Google Scholar
• ANG LH: Outbreak of giardiasis in daycare nursery. Commun. Dis. Public Health (2000) 3:212-213.
   PubMedGoogle Scholar
• NAIMAN HL, SEKLA L, ALBRITTON WL: Giardiasis and other intestinal parasitic infections in a Manitoba residential school for mentally retarded. Can. Med. Assoc. J. (1980) 122:185-188.
   PubMed Web of Science ®Google Scholar
• PAKIANATHAN MR, MCMILLAN A: Intestinal protozoa in homosexual men in Edinburgh. Int. J. STD AIDS (1999) 10:780-784.
   PubMed Web of Science ®Google Scholar
• RENDTORFF RC: The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am. J. Hyg. (1954) 59:209-220.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN F, THORNTON JJ, SZYLDLOWSKI T: Biliary tract dysfunction in giardiasis. Am. J. Dig. Dis. (1978) 23:559-560.
   PubMedGoogle Scholar
• MEYERS JD, KUHARIC HA, HOLMES KK: Giardia lamblia infection in homosexual men. Br. J. Venerol. (1977) 53:54-55.
   PubMedGoogle Scholar
• REYNAERT H, FERNÁNDEZ E, BOURGAIN C, SMEKENS L, DEVIS G: Proton-pump inhibition and gastric giardiasis: a casual or causal association? J. Gastroenterol. (1995) 30:775-778.
   PubMed Web of Science ®Google Scholar
• WIDGREN S, PANCHET B, VOIROL M: Giardia lamblia gastritis. A case report. Rev. Med. Suisse Romande (2001) 121:153-156.
   PubMedGoogle Scholar
• OBERHUBER G, STOLTE M, BETHKE B, RITTER M, EIDT H: Gastric giardiasis: analysis of biopsy specimens from 191 patients infected with Giardia lamblia. Eur. J. Gastroeneterol. Hepatol. (1993) 5:357-360.
   Web of Science ®Google Scholar
• OBERHUBER G, KASTNER N, STOLTE M: Giardiasis: a histologic analysis of 567 cases. Scand. J. Gastroenterol. (1997) 32:48-51.
   PubMed Web of Science ®Google Scholar
• NAKANO I, MIYAHARA T, ITO T, MIGITA Y, NAWATA H: Giardiasis in pancreas. Lancet (1995) 345:524-525.
   PubMedGoogle Scholar
• LUJAN HD, MOWATT MR, NASH TE: Mechanism of Giardia lamblia differentiation into cysts. Microbiol. Mol. Biol. Rev. (1997) 61:294-304.
   PubMed Web of Science ®Google Scholar
• JARROLL EL, BINGHAM AK, MEYER EA: Effect of chlorine on Giardia lamblia cysts viability. Appl. Environ. Microbiol. (1981) 41:483-487.
   PubMed Web of Science ®Google Scholar
• ROBERTSON LJ: Severe giardiasis and cryptosporidiosis in Scotland, UK. Epidemiol. Infect. (1996) 117:551-561.
   PubMed Web of Science ®Google Scholar
• SINGH KD, BHASIN DK, RANA SV et al.: Effect of Giardia lamblia on duodenal disaccharidase levels in humans. Trop. Gastroenterol. (2000) 21:174-176.
   PubMedGoogle Scholar
• MOYA-CAMARENA SY, SOTELO N, VALENCIA ME: Effects of asymptomatic Giardia intestinalis infection on carbohydrate absorption in well-nourished Mexican children. Am. J. Trop. Med. Hyg. (2002) 66:255-259.
   PubMed Web of Science ®Google Scholar
• SIMSEK Z, ZEYREK FY, KURCER MA: Effect of Giardia infection on growth and phychomotor development of children aged 0 – 5 years. J. Trop. Pediatr. (2004) 50:90-93.
   PubMed Web of Science ®Google Scholar
• FRASER D, BILENKO N, DECKELBAUM RJ, DAGAN R, EL-ON J, NAGGAN L: Giardia lamblia carriage in Israeli Bedouin infants: risk factors and consequences. Clin. Infect. Dis. (2000) 30:419-424.
   PubMed Web of Science ®Google Scholar
• KILIC E, YAZAR S, SARAYMEN R: Responsiveness of total content changes of magnesium and zinc status in patients infected with Giardia intestinalis. Biol. Trace Eli. Res. (2003) 96:153-158.
   PubMed Web of Science ®Google Scholar
• ROBERTS-THOMSON IC, ANDERS RF, BHATHAL PS: Granulomatous hepatitis and cholangitis associated with giardiasis. Gastroenterology (1982) 2:480-483.
   Google Scholar
• GRANT SCD, HARRINGTON CI, HARRIS SC: Aphthous ulceration as a presentation of Giardia lamblia infection. Br. Den. J. (1989) 166:457.
   PubMed Web of Science ®Google Scholar
• LETTS M, DAVIDSON D, LALONDE F: Synovitis secondary to giardiasis in children. Am. J. Orthop. (1998) 27:451-454.
   PubMedGoogle Scholar
• LEBLANC CM, BIRDI N: Giardia lamblia associated arthritis in a 19-month-old child (letter). J. Rheumatol. (1999) 26:2066-2067.
   PubMed Web of Science ®Google Scholar
• MEZA-ORTIZ F: Giardiasis-associated arthralgia in children. Arch. Med. Res. (2001) 32:248-250.
   PubMed Web of Science ®Google Scholar
• DI PRISCO MC, HAGEL I, LYNCH NR, et al.: Association between giardiasis and allergy. Ann. Allergy Asthma Immunol. (1998) 81:261-265.
   PubMed Web of Science ®Google Scholar
• ROBERTS DM, CRAFT JC, MATHER FJ, DAVIS SH, WRIGHT JA Jr: Prevalence of giardiasis in patients with cystic fibrosis. J. Pediatr. (1998) 112:555-559.
   Google Scholar
• WALKOWIAK J, KRAWCZYNSKI M, HERZIG K-H: Giardiasis aggravates malabsorption in cystic fibrosis. Scand. J. Gastroenterol. (2004) 39:607-608.
   PubMed Web of Science ®Google Scholar
• FENOLLAR F, LEPIDI H, GÉROLAMI R, DRANCOURT M, RAOULT D: Whipple disease associated with giardiasis. J. Infect. Dis. (2003) 188:828-834.
   PubMed Web of Science ®Google Scholar
• BELSHEIM M, CHAMPION M, SULLIVAN S, TROSTER M: Concurrent Whipple's disease and Giardia lamblia infection. Can. Med. Assoc. J. (1980) 123:394-396.
   PubMed Web of Science ®Google Scholar
• BASSOTTI G, PELLI M, RIBACCHI R et al.: Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am. J. Gastroenterol. (1991) 86:371-374.
   PubMed Web of Science ®Google Scholar
• RUIZ MONTES F, RENE ESPINET J: Whipple's disease, Giardia lamblia, and AIDS enteropathy: clarification of some concepts. Am. J. Gastroenterol. (1993) 88:1133-1134.
   PubMedGoogle Scholar
• GISBERTZ I, BERGMANS D, VAN MARRION-KIEVIT J, HAAK H: Concurrent Whipple's disease and Giardia lamblia infection in a patient presenting with weight loss. Eur. J. Intern. Med. (2001) 12:525-528.
   PubMedGoogle Scholar
• CARROCCIO A, CAVATAIO F, MONTALTO G, PAPARO F, TRONCONE R, IACONO G: Treatment of giardiasis reverses ‘active’ coeliac disease to ‘latent’ celiac disease. Eur. J. Gastroenterol. Hepatol. (2001) 13:1-5.
   PubMed Web of Science ®Google Scholar
• TURSI A, BRANDIMARTE G, GIORGETTI G: High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am. J. Gastroentrol. (2003) 98:720-722.
   PubMed Web of Science ®Google Scholar
• OZCAY F, HARMANCI K, OZBEK N: Giardiasis as a cause of oedema and hypoproteinaemia in a child. Ann. Trop. Paediatr. (2003) 23:153-154.
   PubMedGoogle Scholar
• KHAW M, PANOSIAN CB: Human antiprotozoal therapy: past, present, and future. Clin. Microbiol. Rev. (1995) 8:427-439.
   PubMed Web of Science ®Google Scholar
• MAEDA K, OSATO T, UMEZAWA H: A new antibiotic, azomycin. J. Antibiot. A. (1953) 6:182.
   PubMedGoogle Scholar
• SCHNEIDER J: Traitement de la giardiase (lambliase) par le metronidazole. Bull. Soc. Pathol. Exot. Filiales (1961) 54:84-95.
   PubMedGoogle Scholar
• MANDOUL R, DARGELOS R, MILLAN J: Destruction des protozoaires intestinaux de la souris par un dérivé nitré de l'imidazole. Bull. Soc. Pathol. Exot. Filiales (1961) 54:12-16.
   PubMedGoogle Scholar
• DARBON A, PORTAL A, GIRIER L, PANTIN J, LECLAIRE C: Traitement de la giardiase (lambliase) par le metronidazole. Presse Med. (1962) 70:15-16.
   Web of Science ®Google Scholar
• SCHVARTSMAN S, AMATO-NETO V, CAPP AB, FIORE FF: Nota preliminar sôbre o tratamento da giadíase por um nôvo derivado do metronidazol (9712 R.P.). O Hospital (1964) 65:115-119.
   Google Scholar
• CARDOSO-SALLES JM, AMARAL-ACOSTA C, FREITAS-MATOS L: Avaliaςão da atividade da nitrimidazina na giardíase e trichomoníase genital. O Hospital (1970) 77:257-265.
   Google Scholar
• ANDERSSON T, FORSSELL J, STERNER G: Outbreak of giardiasis: effect of a new antiflagellate drug, tinidazole. Br. Med. J. (1972) 2:449-451.
   PubMedGoogle Scholar
• GANDAHUSADA S, RUKMONO B, RASAD R: Double blind trial of RO-7-0207 (Roche) and metronidazole in the treatment of the intestinal giardiasis. Majalah Kedokteran Indonesia (1974) 14:398-404.
   Google Scholar
• GILLIS JC, WISEMAN LR: Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs (1996) 51:621-638.
   PubMed Web of Science ®Google Scholar
• RAETHER W, HÄNEL H: Nitroheterocyclic drugs with broad spectrum activity. Parasitol. Res. (2003) 90(Suppl.):19-39.
   PubMed Web of Science ®Google Scholar
• UPCROFT J, UPCROFT P: My favorite cell: Giardia. Bioessays (1998) 20:256-263.
   PubMed Web of Science ®Google Scholar
• PAGET TE, JARROLL EL, MANNING P, LINDMARK DG, LlOYD D: Respiration in the cysts and trophozoites of Giardia muris. J. Gen. Microbiol. (1989) 135:145-154.
   PubMedGoogle Scholar
• BASSILY S, FARID Z, MIKHAIL JW, KENT DC, LEHMAN JS: The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone. J. Trop. Med. Hyg. (1970) 73:15-18.
   PubMed Web of Science ®Google Scholar
• JOKIPII L, JOKIPII AM: Comparison of four dosage schedules in the treatment of giardiasis with metronidazole. Infection (1978) 6:92-94.
   PubMed Web of Science ®Google Scholar
• SABCHAREON A, CHONSUPHJAISIDDHI T, ATTANATH P: Treatment of giardiasis in children with quinacrine, metronidazole, tinidazole and ornidazole. Southeast Asian J. Trop. Med. Public Health (1980) 11:280-284.
   PubMedGoogle Scholar
• QUEIROS-BUELNA E: Furazolidone and metronidazole for treatment of giardiasis in children. Scand. J. Gastroenterol. (1989) 169(Suppl.):65-69.
   Google Scholar
• BASSILY S, FARID Z, EL-MASRY NA, MIKHAIL EM: Treatment of intestinal E. histolytica and G. lamblia with metronidazole, tinidazole and ornidazole: a comparative study. J. Trop. Med. Hyg. (1987) 90:9-12.
   PubMed Web of Science ®Google Scholar
• OREN B, SCHGURENSKY E, EPHROS M, TAMIR I, RAZ R: Single dose ornidazole versus seven-day metronidazole therapy of giardiasis in Kibbutzin children in Isarael. Eur. J. Clin. Microbiol. Infect. Dis. (1991) 10:963-965.
   PubMed Web of Science ®Google Scholar
• HALL A, NAHAR Q: Albendazole as a treatment for infections with Giardia intestinalis in children in Bangladesh. Trans. R. Soc. Trop. Med. Hyg. (1993) 87:84-86.
   PubMed Web of Science ®Google Scholar
• DUTTA AK, PHADKE MA, BAGADE AC et al.: A randomised multicentre study to compare the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children. Indian J. Pediatr. (1994) 61:689-693.
   PubMedGoogle Scholar
• MISRA PK, KUMAR A, AGARWAL V, JAGOTA SC: A comparative clinical trial of albendazole versus metronidazole in children with giardiasis. Indian Pediatr. (1995) 32:779-782.
   PubMedGoogle Scholar
• ROMERO-CABELLO R, ROBERT L, MUÑÓZ-GARCÍA R, TANAKA J: Estudio aleatorio para comparar seguridad y eficacia de albendazol y metronidazol en el tratamiento de giardiasis en niños. Rev. Latinoam. Microbiol. (1995) 37:315-323.
   PubMedGoogle Scholar
• RODRÍGUEZ-GARCÍA R, ABURTO-BANDAL M, SÁNCHEZ-MALDONADO MI: Eficacia del albendazol en el tratamiento de giardiasis en niños. Bol. Med. Hosp. Infact. Mex. (1996) 53:173-178.
   Google Scholar
• CHAN DEL PINO M, CUEVA CORNEJO LP, TROYES RIVERA L: Comparación de albendazol con nitrofuranos y nitroimidazoles en el tratamiento de giardiasis en niños. Rev. Gastroenterol. Peru (1999) 19:95-108.
   PubMedGoogle Scholar
• ORTIZ JJ, AYOUB A, GARGALA G, CHEGNE NL, FAVENNEC L: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Aliment. Pharmacol. Ther. (2001) 15:1409-1415.
   PubMed Web of Science ®Google Scholar
• SADJJADI SM, ALBORZI AW, MOSTOVFI H: Comparative clinical trial of mebendazole and metronidazole in giardiasis of children. J. Trop. Pediatr. (2001) 47:176-178.
   PubMed Web of Science ®Google Scholar
• BAQAI R, ZUBERI SJ, QURESHI H, AHMED W, HAFIZ S: Efficacy of albendazole in giardiasis. East Mediterr. Health J. (2001) 7:787-790.
   PubMedGoogle Scholar
• OZBILGIN A, ERTAN P, YERELI K et al.: Giardiasis treatment in Turkish children with single dose of ornidazole. Scand. J. Infect. Dis. (2002) 34:918-920.
   PubMed Web of Science ®Google Scholar
• YERELI K, BALCIOGLU IC, ERTAN P, LIMONCU E, ONAG A: Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey. Clin. Microbiol. Infect. (2004) 10:527-529.
   PubMed Web of Science ®Google Scholar
• KARABAY O, TAMER A, GUNDUZ H, KAYAS D, ARINC H, CELEBI H: Albendazole versus metronidazole treatment of adult giardiasis: an open randomised clinical study. World J. Gastroenterol. (2004) 20:1215-1217.
   Google Scholar
• SAFFAR MJ, QUFFARI J, KHALILIAN AR, KOSARIAN M: Rapid reinfection by Giardia lamblia after treatment in an hyperendemic area: the case against treatment. East Mediterr. Health J. (2005) 11:73-78.
   PubMedGoogle Scholar
• JOKIPII L, JOKIPII AM: Single-dose metronidazole and tinidazole as therapy for giardiasis: success rates, side effects, and drug absorption and elimination. J. Infect. Dis. (1979) 140:984-988.
   PubMed Web of Science ®Google Scholar
• GAZDER AJ, BANERJEE M: Single dose therapy of giardiasis with tinidazole and metronidazole. Drugs (1978) 15(Suppl. 1):30-32.
   PubMed Web of Science ®Google Scholar
• SPEELMAN P: Single-dose of tinidazole for the treatment of giardiasis. Antimicrob. Agents Chemother. (1985) 27:227-229.
   PubMed Web of Science ®Google Scholar
• KYRONSEPPA H, PETERSSON T: Treatment of giardiasis: relative efficacy of metronidazole as compared with tinidazole. Scand. J. Infect. Dis. (1981) 13:311-312.
   PubMed Web of Science ®Google Scholar
• BULUT BU, GULNAR SB, AYSEV D: Alternative protocols in giardiasis: a pilot study. Scand. J. Infect. Dis. (1996) 28:493-495.
   PubMed Web of Science ®Google Scholar
• KUSUMI RK, PLOUFFE JF, WYATT RH, FASS RJ: Central nervous system toxicity associated with metronidazole therapy. Ann. Intern. Med. (1980) 93:59-60.
   PubMed Web of Science ®Google Scholar
• ROSENKRANZ HS, SPECK WT: Mutagenicity of metronidazole: activation by mammalian liver microsomes. Biochem. Biophys. Res. Commun. (1975) 66:520-525.
   PubMed Web of Science ®Google Scholar
• VOOGD CE: On the mutagenicity of nitroimidazoles. Mutag. Res. (1981) 86:243-277.
   PubMed Web of Science ®Google Scholar
• LOPEZ NIGRO MM, PALERMO AM, MUDRY MD, CARBALLO MA: Cytogenetic evaluation of two nitroimidazale derivatives. Toxicol. In Vitro (2003) 17:35-40.
   PubMed Web of Science ®Google Scholar
• FALAGAS ME, WALKER AM, JICK H, RUTHAZER R, GRIFFITH J, SNYDMAN DR: Late incidence of cancer after metronidazole use: a matched metronidazole user/nonuser study. Clin. Infect. Dis. (1998) 26:384-388.
   PubMed Web of Science ®Google Scholar
• JOKIPII L, JOKIPII AMM: In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole. J. Infect. Dis. (1980) 141:317-325.
   PubMed Web of Science ®Google Scholar
• GORDTS LS, HEMELHOF W, ASSELMAN C, BUTZLER J: In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents. Antimicrob. Agents Chemother. (1985) 28:378-380.
   PubMed Web of Science ®Google Scholar
• PONCE-MACOTELA M, GÓMEZ-GARDUÑO J, GONZÁLEZ-MACIEL A, REYNOSO-ROBLES R, ANISLADO-TOLENTINO V, MARTÍNEZ-GORDILLO MN: In vitro determination of Giardia susceptibility to nitazoxanide in four isolates from different hosts. Rev. Invest. Med. (2001) 53:41-45.
   Google Scholar
• JOKIPII AMM, JOKIPII L: Comparative evaluation of two dosages of tinidazole in the treatment of giardiasis. Am. J. Trop. Med. Hyg. (1978) 27:758-761.
   PubMed Web of Science ®Google Scholar
• NIGAM P, KAPOOR KK, KUMAR A et al.: Clinical profile of giardiasis and comparison of its therapeutic response to metronidazole and tinidazole. J. Assoc. Physicians India (1991) 39:613-615.
   PubMedGoogle Scholar
• CIMERMAN B, COURA LC, SALLES JMC et al.: Evaluation of secnidazol gel and tinidazole suspension in the treatment of giardiasis in children. Braz. J. Infect. Dis. (1997) 1:241-247.
   PubMedGoogle Scholar
• PENGSAA K, SIRIVICHAYAKUL C, POJJAROEN-ANAT C et al.: Albendazole treatment for Giardia intestinalis infections in school children. Southeast Asian J. Trop. Med. Publ. Health (1999) 30:78-83.
   PubMedGoogle Scholar
• ESCOBEDO AA, NÚÑEZ FA, MOREIRA I, VEGA E, PAREJA A, ALMIRALL P: Chloroquine and albendazole in the treatment of paediatric patients with giardiasis. Ann. Trop. Med. Parasitol. (2003) 97:367-371.
   PubMed Web of Science ®Google Scholar
• MENDOZA D, NÚÑEZ FA, ESCOBEDO AA et al.: Utilidad de 2 métodos coproparasitológicos y su empleo en un ensayo terapéutico antigiardiasico. Rev. Cubana Med. Trop. (2003) 55:174-178.
   PubMedGoogle Scholar
• CAÑETE R, ESCOBEDO AA, GONZÁLEZ ME, ALMIRALL P, CANTELAR N: A randomised, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children. Curr. Med. Res. Opin. (2006) 22:2131-2138.
   PubMed Web of Science ®Google Scholar
• ESCOBEDO AA, ALVAREZ G, GONZÁLEZ ME et al.: A comparative trial of a single-dose tinidazole versus three days of nitazoxanide for the treatment of giardiasis in children. Ann. Trop. Med. Parasitol. (2007) under submission.
   Google Scholar
• CASTAÑEDA GUILLOT C, SAGARÓ GONZÁLEZ E, BLANCO RABASA E: El tinidazol, su utilidad en el tratamiento de la giardiasis recidivante de la infancia. Informe preliminary. Rev. Cubana Med. Trop. (1984) 36:368-375.
   PubMedGoogle Scholar
• JOKIPII L, JOKIPII AMM: Treatment of giardiasis: comparative evaluation of ornidazole and tinidazole as a single oral dose. Gastroenterology (1982) 83:399-404.
   PubMed Web of Science ®Google Scholar
• COULTER JR, TURNER JV: Tinidazole is mutagenic in a Salmonella typhimurium assay. Mutat. Res. (1978) 57:97-101.
   PubMedGoogle Scholar
• LOPEZ NIGRO MM, GADANO AB, CARBALLO MA: Evaluation of genetic damage induced by a nitroimidazole derivative in human lymphocytes: Tinidazole (TNZ). Toxicol. In Vitro (2001) 15:209-213.
   PubMed Web of Science ®Google Scholar
• IYNGKARAN N, LEE IL, ROBINSON MJ: Single dose treatment with Tiberal of Giardia lamblia infection in children. Scand. J. Infect. Dis. (1978) 10:243-246.
   PubMed Web of Science ®Google Scholar
• AMOROTO M, FERNÁNDEZ M, GONZÁLEZ ME et al.: Eficacia del Aceite ozonizado (Oleozón) en el tratamiento de la giardiasis. Ensayo clínico Fase III, aleatorizado, abierto y controlado. Rev. Cubana Farmacol. (2002) 36(Suppl.):173-175.
   Google Scholar
• TABAK F, OZARAS R, ERZIN Y, CELIK AF, OZBAY G, SENTURK H: Ornidazole-induced liver damage: report of three cases and review of the literature. Liver Int. (2003) 23:351-354.
   PubMed Web of Science ®Google Scholar
• FAVENNEE L, GOBERT JC: A new screening assay for antigiardial compounds: effects of various drugs on the adherence of Giardia duodenalis to CaCo2 cells. Parasitol. Res. (1992) 78:80-81.
   PubMed Web of Science ®Google Scholar
• RASTEGAR-LARI A, SALEK-MOGHADDAM A: Single-dose secnidazole versus 10-day metronidazole therapy of giardiasis in Iranian children. J. Trop. Pediatr. (1996) 42:184-185.
   PubMed Web of Science ®Google Scholar
• DI PRISCO MC, JIMENEZ JC, RODRIGUEZ N et al.: Clinical trial with secnidazole in a single dose in Venezuelan children infected by Giardia intestinalis. Invest. Clin. (2000) 41:179-188.
   PubMedGoogle Scholar
• ESCOBEDO AA, CAÑETE R, GONZÁLEZ ME, PAREJA A, CIMERMAN S, ALMIRALL P: A randomized trial comparing mebendazole and secnidazole against giardiasis. Ann. Trop. Med. Parasitol. (2003) 97:499-505.
   PubMed Web of Science ®Google Scholar
• GILLIS JC, WISEMAN LR: Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs (1996) 51:621-638.
   PubMed Web of Science ®Google Scholar
• GALLI-VALERIO B: La lambliase et son traitement par l'atebrine. Schweiz Med. Wochenschr. (1937) 67:1181-1182.
   Google Scholar
• PAGET TA, JARROLL EL, MANNING P, LINDMARK DG, LLOYD D: Respiration in the cyst and trophozoite forms of Giardia muris. J. Gen. Microbiol. (1989) 135:145-154.
   PubMedGoogle Scholar
• HARDER A, GREIF G, HABERKORN A: Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba – current level of knowledge and outlook. Parasitol. Res. (2001) 87:785-786.
   PubMed Web of Science ®Google Scholar
• NAMGUNG R, RYU JS, LEE KT, SOH CT: The effect of metronidazole and quinacrine on the morphology and the excystation of Giardia lamblia. Yonsei Rep. Trop. Med. (1985) 16:28-44.
   Google Scholar
• GILLIN FD, DIAMOND LS: Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine and other antimicrobial agents. J. Antimicrob. Chemother. (1981) 8:305-316.
   PubMed Web of Science ®Google Scholar
• KAVOUSI S: Giardiasis in infancy and chilhood: a prospective study of 160 cases with comparison of quinacrine (Atabrine ®) and metronidazole (Flagyl®). Am. J. Trop. Med. Hyg. (1979) 28:19-23.
   PubMed Web of Science ®Google Scholar
• CRAFT JC, MURPHY T, NELSON JD: Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children. Am. J. Dis. Child. (1981) 135:164-166.
   PubMedGoogle Scholar
• CAÑETE R, ESCOBEDO AA, GONZÁLEZ ME, ALMIRALL P: Randomized clinical study of five days' therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis. World J. Gastroenterol. (2006) 12:6366-6370.
   PubMed Web of Science ®Google Scholar
• GARDNER TB, HILL DR: Treatment of Giardiasis. Clin. Microbiol. Rev. (2001) 14:114-128.
   PubMed Web of Science ®Google Scholar
• GENEL F, ERERMIS S, AKSU G, OZTURK C, KUTUKCULER N: Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis. Hum. Psychopharmacol. (2002) 17:357-359.
   PubMed Web of Science ®Google Scholar
• WEBSTER BH: Furazolidone in the treatment of giardiasis. Am. J. Dig. Dis. (1960) 5:618-622.
   PubMedGoogle Scholar
• CROUCH AA, SEOW WK, THONG YH: Effect of twenty-three chemotherapeutic agents on the adherence and growth of Giardia lamblia in vitro. Trans. R. Soc. Trop. Med. Hyg. (1986) 80:893-896.
   PubMed Web of Science ®Google Scholar
• CAMPANATI L, MONTEIRO-LEAL LH: The effects of the antiprotozoal drugs metronidazole and furazolidone on trophozoites of Giardia lamblia (P1 strain). Parasitol. Res. (2002) 88:80-85.
   PubMed Web of Science ®Google Scholar
• FARBEY MD REYNOLDSON JA, THOMPSON RC: In vitro drug susceptibility of 29 isolates of Giardia intestinalis from humans as assessed by an adhesion assay. Int. J. Parasitol. (1995) 25:593-599.
   PubMed Web of Science ®Google Scholar
• BOREHAM PFL, PHILLIPS RE, SHEPHERD RW: A comparison of the in-vitro activity of some 5-nitroimidazoles and other compounds against Giardia intestinalis. J. Antimicrob. Chemother. (1985) 16:589-595.
   PubMed Web of Science ®Google Scholar
• GARG BK: Furazolidone and metronidazole in the treatment of giardiasis. Indian J. Pediatr. (1972) 39:264-266.
   PubMedGoogle Scholar
• MURPHY TV, NELSON JD: Five v ten days' therapy with furazolidone for giardiasis. Am. J. Dis. Child. (1983) 137:267-270.
   PubMedGoogle Scholar
• ELLIOTT AM, KLAUS BD, NORTH DS, MARTIN HP: Furazolidone-induced mood disorder during the treatment of refractory giardiasis in a patient with AIDS. Clin. Infect. Dis. (1998) 26:1015.
   PubMed Web of Science ®Google Scholar
• KREUTNER A, DEL BENE VE, AMSTEY MS: Giardiasis in pregnancy. Am. J. Obstet. Gynecol. (1981) 140:895-901.
   PubMed Web of Science ®Google Scholar
• AWADALLA HN, EL-GOWHARY SH, SADAKA HAH, KHALIFA AM: Aminosidine sulphate in experimental giardiasis. J. Egypt. Soc. Parasitol. (1995) 25:53-61.
   PubMedGoogle Scholar
• BOREHAM PFL, PHILLIPS RE, SHEPHERD RW: The activity of drugs against Giardia intestinalis in neonatal mice. J. Antimicrob. Chemother. (1986) 18:393-398.
   PubMed Web of Science ®Google Scholar
• KATIYAR S, VIVESVARA G, EDLIND T: Comparisons of the ribosomal RNA from amitochondrial protozoa: implications for processing, mRNA binding and paromomycin susceptibility. Gene (1995) 152:27-33.
   PubMed Web of Science ®Google Scholar
• CARTER CH, BAYLES A, THOMPSON PE: Effects of paromomicyn sulfate in man against Entamoeba histolytica and other intestinal protozoa. Am. J. Trop. Med. Hyg. (1962) 62:448-451.
   Google Scholar
• PALOMINO H, PÉREZ C, DONCKASTER R et al.: Ensayo terapéutico con cinco medicamentos en lambliasis. Bol. Chil. Parasitol. (1970) 25:52-56.
   PubMedGoogle Scholar
• NÚÑEZ FA, ESCOBEDO AA, FINLAY CM: Eficacia de varios esquemas de tratamiento para la infección por Giardia lamblia en niños. Rev. Panam. Infectol. (2004) 6:17-20.
   Google Scholar
• MORGAN UM, REYNOLDSON JA, THOMPSON RC: Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro. Antimicrob. Agents Chemother. (1993) 37:328-331.
   Google Scholar
• DE SILVA N, GUYATT H, BUNDY D: Anthelmintics: a comparative review of their clinical pharmacology. Drugs (1997) 53:769-788.
   PubMed Web of Science ®Google Scholar
• KATELARIS PH, NAEEM A, FARTHING MJ: Activity of metronidazole, azithromycin and three benzimidazoles on Giardia lamblia growth and attachment to a human intestinal cell line. Aliment. Pharmacol. Ther. (1994) 8:187-192.
   PubMed Web of Science ®Google Scholar
• EDLIND TD, HANG TL, CHAKRABORTY PR: Activity of the anthelminthic benzimidazoles against Giardia duodenalis in vitro. J. Infect. Dis. (1990) 162:1408-1411.
   PubMed Web of Science ®Google Scholar
• HUTCHISON JG, JOHNSON MN, PLEVEY MV, THANGKHIEW I, ALDNEY C: Clinical trial of mebendazole, a broad-spectrum anthelminthic. Br. Med. J. (1975) 02:309-310.
   Google Scholar
• CEDILLO-RIVERA R, MUÑOZ O: In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. J. Med. Microbiol. (1992) 37:221-224.
   PubMed Web of Science ®Google Scholar
• CHAVEZ B, CEDILLO-RIVERA R, MARTÍNEZ-PALOMO A: Giardia lamblia: ultrastructural study of the in vitro effect of benzimidazoles. J. Protozool. (1992) 39:510-515.
   PubMedGoogle Scholar
• KATIYAR SK, GORDON VR, MCLAUGHLIN GL, EDLIND TD: Antiprotozoal activities of benzimidazoles and correlations with β-tubulin sequence. Antimicrob. Agents Chemother. (1994) 38:2086-2090.
   PubMed Web of Science ®Google Scholar
• MACDONALD LM, ARMSON A, THOMPSON RCA, REYNOLDSON JA: Characterization of benzimidazole binding with recombinant tubulin from Giardia duodenalis, Encephalitozoon intestinalis, and Cryptosporidium parvum. Mol. Biochem. Parasitol. (2004) 138:89-96.
   PubMed Web of Science ®Google Scholar
• AL-WAILI NS, AL-WAILI BH, SALOOM KY: Therapeutic use of mebendazole in giardial infections. Trans. R. Soc. Trop. Med. Hyg. (1988) 82:438.
   PubMed Web of Science ®Google Scholar
• GASCON J, MORENO A, VALLS MR, MIRO JM, CORACHAN M: Failure of mebendazole treatment in Giardia lamblia infection. Trans. R. Soc. Trop. Med. Hyg. (1989) 83:647.
   PubMed Web of Science ®Google Scholar
• DI MARTINO L, NOCERINO A, MANTOVANI MP: Mebendazole in giardial infections: confirmation of failure of treatment. Trans. R. Soc. Trop. Med. Hyg. (1991) 85:557-558.
   Google Scholar
• ROUSHAM EK: An increase in Giardia duodenalis infection among children receiving periodic anthelmintic treatment in Bangladesh. J. Trop. Pediatr. (1994) 40:329-333.
   PubMed Web of Science ®Google Scholar
• BULUT BU, GULNAR SB, AYSEV D: Alternative treatment protocols in giardiasis: a pilot study. Scand. J. Infect. Dis. (1996) 28:493-495.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ-GARCIA R, RODRIGUEZ-GUZMAN LM, CRUZ DEL CASTILLO AH: Eficacia y seguridad de mebendazole contra nitazoxanida en el tratamiento de Giardia lamblia en niños. Rev. Gastroenterol. Mex. (1999) 64:122-126.
   PubMedGoogle Scholar
• ACS N, BANHIDY F, PUHO E, CZEIZEL AE: Population-based case-control study of mebendazole in pregnant women for birth outcomes. Congenit Anom (Kyoto) (2005) 45:85-88.
   PubMedGoogle Scholar
• DIAV-CITRIN O, SHECHTMAN S, ARNON J, LUBART I, ORNOY A: Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study. Am. J. Obstet. Gynecol.(2002) 188:282-285.
   Web of Science ®Google Scholar
• GYORKOS TW, LAROCQUE R, CASAPIA M, GOTUZZO E: Lack of risk of adverse birth outcomes after deworming in pregnant women. Pediatr. Infect. Dis. J. (2006) 25:791-794.
   PubMed Web of Science ®Google Scholar
• MELONI BP, THOMPSON RC, REYNOLDSON JA, SEVILLE P: Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole. Trans. R. Soc. Trop. Med. Hyg. (1990) 84:375-379.
   PubMed Web of Science ®Google Scholar
• REYNOLDSON JA, THOMPSON RC, MELONI BP et al.: In vivo efficacy of albendazole against Giardia duodenalis in mice. Parasitol. Res. (1991) 77:325-328.
   PubMed Web of Science ®Google Scholar
• PENGSAA K, LIMKITTIKUL K, POJJAROEN-ANAT C et al.: Single-dose therapy for giardiasis in school-age children. Southeast Asian J. Trop. Med. Public Health (2002) 33:711-717.
   PubMedGoogle Scholar
• KOLLARITSCH H, JESCHKO E, WIEDERMAN G: Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: Results of an open pilot trial in travellers returning from the tropics. Trans. R. Soc. Trop. Med. Hyg. (1993) 87:689.
   PubMedGoogle Scholar
• HORTON J: Albendazole: a broad spectrum anthelmintic for treatment of individuals and populations. Curr. Opin. Infect. Dis. (2002) 15:599-608.
   PubMed Web of Science ®Google Scholar
• MERINO G, MOLINA AJ, GARCIA JL, PILIDO MM, PRIETO JG, ALVAREZ AI: Intestinal elimination of albendazole sulfoxide: pharmacokinetic effect of inhibitors. Int. J. Pharm. (2003) 263:123-132.
   PubMedGoogle Scholar
• MERINO G, MOLINA AJ, GARCIA JL, PILIDO MM, PRIETO JG, ALVAREZ AI: Ginseng increases intestinal elimination of albendazole sulfoxide in the rat. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. (2003) 136:9-15.
   PubMed Web of Science ®Google Scholar
• BRADLEY M, HORTON J: Assessing the risk of benzimidazole therapy during pregnancy. Trans. R. Soc. Trop. Med. Hyg. (2001) 95:72-73.
   PubMed Web of Science ®Google Scholar
• GYAPONG JO, CHINBUAH MA, GYAPONG M: Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis. Trop. Med. Int. Health (2003) 8:1093-1101.
   PubMed Web of Science ®Google Scholar
• CEDILLO-RIVERA R, CHÁVEZ B, GONZÁLEZ-ROBLES A, TAPIA A, YÁPEZ-MULIA L: In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. J. Eukariot. Microbiol. (2002) 49:201-208.
   PubMed Web of Science ®Google Scholar
• ADAGU SI, NOLDER D, WARHURST DC, ROSSIGNOL J-F: In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. (2002) 49:103-111.
   PubMed Web of Science ®Google Scholar
• BERNAL-REDONDO R, MARTINEZ-MENDEZ LG, MENDOZA-CHAVEZ A et al.: Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts. J. Submicrose Cytol. Pathol. (2004) 36:241-245.
   PubMedGoogle Scholar
• STOCKIS A, ALLEMON AM, DEBRUYM S, GENGLER C: Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses. Int. J. Clin. Pharmacol. Ther. (2002) 40:213-220.
   PubMed Web of Science ®Google Scholar
• BROEKHUYSEN J, STOCKIS A, LINS RL, DE GRAEVE J, ROSSIGNOL JF: Nitazoxanide, pharmacokinetics and metabolism in man. Int. J. Clin. Pharmacol. Ther. (2000) 38:387-394.
   PubMed Web of Science ®Google Scholar
• ROSSIGNOL JF, AYOUB A, AYERS MS: Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J. Infect. Dis. (2001) 184:381-384.
   PubMed Web of Science ®Google Scholar
• DAVILA-GUTIERREZ CE, VAZQUEZ C, TRUJILLO-HERNANDEZ B, HUERTA M: Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am. J. Trop. Med. Hyg. (2002) 66:251-254.
   PubMed Web of Science ®Google Scholar
• ABAZA H, EL-ZAYADI A, KABIL SM, RIZK H: Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt. Curr. Ther. Res. (1998) 59:116-121.
   Web of Science ®Google Scholar
• DIAZ E, MONDRAGÓN J, RAMIREZ E, BERNAL R: Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am. J. Trop. Med. Hyg. (2003) 68:384-385.
   PubMed Web of Science ®Google Scholar
• ROMERO CABELLO R, GUERRERO LR, MUNOZ GARCIA, GEYNE CRUZ A: Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans. R. Soc. Trop. Med. Hyg. (1997) 91:701-703.
   PubMed Web of Science ®Google Scholar
• ABBOUD P, LEMEE V, GARGALA G et al.: Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. (2001) 32:1792-1794.
   PubMed Web of Science ®Google Scholar
• STOCKIS A, DEROUBAIX X, LINS R, JEANBAPTISTE B, CALDERON P, ROSSIGNOL JF: Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. Int. J. Clin. Pharmacol. Ther. (1996) 34:349-351.
   PubMed Web of Science ®Google Scholar
• TAKEUCHI T, KOBAYASHI S, TANABE M, FUJIWARA T: In vitro inhibition of Giardia lamblia and Trichomonas vaginalis growth by bithionol, dichlorophene, and hexachlorophene. Antimicrob. Agents Chemother. (1985) 27:65-70.
   PubMed Web of Science ®Google Scholar
• WEINBANC EC, COSTA JL, WEIDER SC: Antidepressant drugs suppress growth of the human pathogenic protozoan Giardia lamblia. Res. Commun. Chem. Pathol. Pharmacol. (1985) 47:145-148.
   PubMedGoogle Scholar
• EDLIND TD: Tetracyclines as antiparasitic agents: lipophilic derivatives are highly active against Giardia lamblia in vitro. Antimicrob. Agents Chemother. (1989) 33:2144-2145.
   PubMed Web of Science ®Google Scholar
• FARTHING MJG, INGE PMG: Antigiardial activity of the bile salt-life antibiotic sodium fusidate. J. Antimicrob. Chemother. (1986) 17:165-171.
   PubMed Web of Science ®Google Scholar
• YOUSSEF M, ESSA M, SADAKA H, EISSA M, RIZK A: Effect of ivermectin on combined intestinal protozoal infection (giardiasis and cryptosporidiosis). J. Egypt Soc. Parasitol. (1996) 26:543-553.
   PubMedGoogle Scholar
• HASAN SI, NESSIM NG, MAHMOUD SS, NOSSEIR MM: Effect of a broad spectrum antiparasitic drug “ivermectin” in acute and chronic experimental giardiasis using different dose regimens. J. Egypt Soc. Parasitol. (2001) 31:419-428.
   PubMedGoogle Scholar
• O'HANDLEY RM, OLSON ME, MCALLISTER TA et al.: Efficacy of fenbendazole for the treatment of giardiasis in calves. Am. J. Vet. Res. (1997) 58:384-388.
   PubMed Web of Science ®Google Scholar
• ZAJAC AM, LABRANCHE TP, DONOGHUE AR et al.: Efficacy of fenbendazole in the treatment of experimental Giardia infection in dogs. Am. J. Vet. Res. (1998) 59:61-63.
   PubMed Web of Science ®Google Scholar
• NASH T, RICE WG: Effectiveness of zinc-finger-active drugs against Giardia lamblia. Antimicrob. Agents Chemother. (1998) 42:1488-1492.
   PubMed Web of Science ®Google Scholar
• SOUSA MC, POIARES-DA-SILVA J: Cytotoxicity induced by bismuth subcitrate in Giardia lamblia trophozoites. Toxicol. In Vitro (1999) 13:591-598.
   PubMed Web of Science ®Google Scholar
• SOUSA MC, POIARES-DA-SILVA J: The cytotoxic effects of ciprofloxacin in Giardia lamblia trophozoites. Toxicol. In Vitro (2001) 15:297-301.
   PubMed Web of Science ®Google Scholar
• BHARTI N, HUSAIN K, GONZALEZ GARZA M et al.: Synthesis and in vitro antiprotozoal activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazone derivatives. Bioorg. Med. Chem. Lett. (2002) 12:3475-3478.
   PubMed Web of Science ®Google Scholar
• VALDEZ J, CEDILLO R, HERNANDEZ-CAMPOS A et al.: Synthesis and antiparasitic activity of 1H-benzimidazole derivatives. Bioorg. Med. Chem. Lett. (2002) 12:2221-2224.
   PubMed Web of Science ®Google Scholar
• ANDRZEJEWSKA M, YEPEZ-MULIA L, CEDILLO-RIVERA R et al.: Synthesis, antiprotozoal and anticancer activity of substituted 2-trifluoromethyl-and 2-pentafluoroethylbezimidazoles. Eur. J. Med. Chem. (2002) 37:973-978.
   PubMed Web of Science ®Google Scholar
• ANDRZEJEWSKA M, YEPEZ-MULIA L, TAPIA A et al.: Synthesis, and antiprotozoal and antibacterial activities of S-substituted 4,6-dibromo- and 4,6-dichloro-2-mercaptobenzimidazoles. Eur. J. Pharm. Sci. (2004) 21:323-329.
   PubMed Web of Science ®Google Scholar
• JIMENEZ-CARDOSO E, FLORES-LUNA A, ANGELES E et al.: In vitro antigiardial activity of IRE-6A and IRE-7B, two ethyl-phenylcarbamate derivatives. Rev. Invest. Clin. (2003) 55:444-447.
   PubMedGoogle Scholar
• PAGET T, MAROULIS S, MITCHELL A, EDWARDS MR, JARROLL EL, LLOYD D: Menadione kills trophozoites and cysts of Giardia intestinalis. Microbiology (2004) 150(Part 5):1231-1236.
   PubMed Web of Science ®Google Scholar
• MARIANTE RM, VANCINI RG, MELO AL, BENCHIMOL M: Giardia lamblia: evaluation of the in vitro effects of nocodazole and colchicines on trophozoites. Exp. Parasitol. (2005) 110:62-72.
   PubMed Web of Science ®Google Scholar
• RAYAN P, STENZEL D, MCDONNELL PA: The effects of satured fatty acids on Giardia duodenalis trophozoites in vitro. Parasitol. Res. (2005) 97:191-200.
   PubMed Web of Science ®Google Scholar
• CHON SK, KIM NS: Evaluation of silymarine in the treatment on asymptomatic Giardia infections in dogs. Parasitol. Res. (2005) 97:445-451.
   PubMed Web of Science ®Google Scholar
• MULLER J, RUHLE G, MULLER N, ROSSIGNOL JF, HEMPHILL A: In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells. Antimicrob. Agents Chemother. (2006) 50:162-170.
   PubMed Web of Science ®Google Scholar
• ANDREWS BJ, MYLVAGANAM H, YULE A: In vitro sensitivity of Trichomonas vaginalis, Trichomonas foetus, and Giardia intestinalis to bacitracin and its zinc salt. Trans. R. Soc. Trop. Med. Hyg. (1994) 88:704-706.
   PubMed Web of Science ®Google Scholar
• ANDREWS BJ, PANITESCU D, JIPA GH, VASILE-BUGARIN AC, VASILIU RP, RONNEVIG JR: Chemotherapy for giardiasis: a randomized clinical trial of bacitracin, bacitracin zinc, and a combination of bacitracin neomycin. Am. J. Trop. Med. Hyg. (1995) 52:318-321.
   PubMed Web of Science ®Google Scholar
• BAVEJA UK, BATHIA VN, WARHURST DC: Giardia lamblia: in-vitro sensitivity to some chemotherapeutic agents. J. Communicable Dis. (1998) 30:79-84.
   PubMedGoogle Scholar
• SCHNEIDER J, UZAN M: Sur l'utilisation d'un nouveau médicament synthétique dans le traitement de la lambliase. Bull. Soc. Pathol. Exotique (1947) 40:155-156.
   Google Scholar
• BASNUEVO JG, SOTOLONGO F: Tratamiento de la giardiasis con aralen (cloroquina). Rev. KUBA de Medicina Tropical y Parasitología (1948) 4:169.
   Google Scholar
• BASNUEVO JG: La quinacrina y los antimaláricos en el tratamiento de la giardiasis. Rev. KUBA de Medicina Tropical y Parasitología (1950) 6:121-123.
   PubMedGoogle Scholar
• BASNUEVO JG, SOLER DELGADO F, COWLEY CHAVEZ O: La mezcla cloroquina-quinacrina (3:1) en el tratamiento de la giardiasis. Rev. KUBA de Medicina Tropical y Parasitología (1954) 10:54-56.
   PubMedGoogle Scholar
• GENC S: The treatment of giardiasis and trichomoniasis with resochin and metronidazole. Mikrobiyol. Bul. (1976) 10:303-306.
   PubMedGoogle Scholar
• POPOVIC O, JOJIC N, MILUTINOVIC-DJURIC S, DJURDJEVIC D, MILOVIC V: Propranolol for metronidazole-resistant giardiasis. Ital. J. Gastroenterol. (1991) 23:359.
   PubMedGoogle Scholar
• FARTHING MJG, INGE PMG, PEARSON RM: Effect of D-propanolol on growth and motility of flagellate protozoa. J. Antimicrob. Chemother. (1987) 20:519-522.
   PubMed Web of Science ®Google Scholar
• TORRES D, HOLLANDS I, PALACIOS E: Efecto de un extracto alcohólico de propóleos sobre el crecimiento de Giardia lamblia in vitro. Rev. Cubana Cienc. Vet. (1990) 21:15-20.
   Google Scholar
• MIYARES C, HOLLANDS I, CASTAÑEDA C et al.: Ensayo terapéutico con un producto preparado a base de propéleo “propolisina” en la giardiasis del humano. Acta Gastroenterol. Latinoam. (1988) 18:195-201.
   PubMedGoogle Scholar
• WICKRAMANAYAKE GB, RUBIN AJ, SPROUL OJ: Inactivation of Giardia cysts with ozone. Appl. Environ. Microbiol. (1984) 48:671-672.
   PubMed Web of Science ®Google Scholar
• WIDMER G, CLANCY T, WARD HD et al.: Structural and biochemical alterations in Giardia lamblia cysts exposed to ozone. J. Parasitol. (2002) 88:1100-1106.
   PubMed Web of Science ®Google Scholar
• KREUTNER AK, DEL BENE VE, AMSTEY MS: Giardiasis in pregnancy. Am. J. Obstet. Gynecol. (1981) 140:895-901.
   PubMed Web of Science ®Google Scholar
• MUDRY MD, MARTINEZ-FLORES I, PALERMO AM, CARBALLO MA, EGOZCUE J, GARCIA CALDES M: Embryolethality induced by metronidazole (MTZ) in Ratus norvegicus. Teratog. Carcinog. Mutagen. (2001) 21:197-205.
   PubMedGoogle Scholar
• DIAV-CITRIN O, SHECHTMAN S, GOTTEINER T, ARNON J, ORNOY A: Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology (2001) 63:186-192.
   PubMedGoogle Scholar
• TELLEZ A, WINIECKA-KRUSNELL J, PANIAGUA M, LINDER E: Antibodies in mother's milk protect children against giardiasis. Scand. J. Infect. Dis. (2003) 35:322-325.
   PubMed Web of Science ®Google Scholar
• FRANCA-BOTELHO AC, HONORIO-FRANCA AC, FRANCA EL, GOMES MA, COSTA-CRUZ JM: Phagocytosis of Giardia lamblia trophozoites by human colostral leukocytes. Acta Paediatr. (2006) 95:438-443.
   PubMed Web of Science ®Google Scholar
• CHANDRA RK: Parasitic infection, nutrition, and immune response. Fed. Proc. (1984) 43:251-255.
   PubMedGoogle Scholar
• FARTHING MJ: Diarrhoeal disease: current concepts and future challenges. Pathogenesis of giardiasis. Trans. R. Soc. Trop. Med. Hyg. (1993) 87(Suppl. 3):17-21.
   PubMed Web of Science ®Google Scholar
• KHATAMI SS, MUKUNDA B, RAVAKHAH K: Coinfection with Giardia lamblia and Clostridium difficile after use of ranitidine. Am. J. Med. Sci. (2004) 327:91-93.
   PubMed Web of Science ®Google Scholar
• KADER SA, MANSOUR AM, MOHRAN Z, EL-TAOIL A, ABDALLA KF: A study on the relation between proton pump inhibitor and gastric giardiasis. J. Egypt Soc. Parasitol. (1998) 28:149-157.
   PubMedGoogle Scholar
• REYNAERT H, FERNANDES E, BOURGAIN C, SMEKENS L, DEVIS G: Proton-pump inhibition and gastric giardiasis: a casual or causal association? J. Gastroenterol. (1995) 30:775-778.
   PubMed Web of Science ®Google Scholar
• SLONIM JM, IRETON HJ, SMALLWOOD RA: Giardiasis following gastric surgery. Aust. NZ J. Med. (1976) 6:479-480.
   PubMedGoogle Scholar
• BIRKHEAD G, JANOFF EN, VOGT RL, SMITH PD: Elevated levels of immunoglobulin A to Giardia lamblia during a waterborne outbreak of gastroenteritis. J. Clin. Microbiol. (1989) 27:1007-1017.
   Google Scholar
• NOURELDIN MS, SHALTOUT AA, EL HAMSHARY EM, ALI ME: Opportunistic intestinal protozoal infections in immunocompromised children. J. Egypt Soc. Parasitol. (1999) 23:951-961.
   Google Scholar
• ESCOBEDO AA, NÚÑEZ FA: Prevalence of intestinal parasites in Cuban acquired immunodeficiency syndrome (AIDS) patients. Acta Trop. (1999) 72:125-130.
   PubMed Web of Science ®Google Scholar
• CIMERMAN S, CIMERMAN B, LEWI DS: Prevalence of intestinal parasitic infections in patients with acquire immunodeficiency syndrome in Brazil. Int. J. Infect. Dis. (1999) 3:203-206.
   PubMedGoogle Scholar
• FONTANET AL, SAHLU T, RINKE T et al.: Epidemiology of infections with intestinal parasites and human immunodeficiency virus (HIV) among sugar-estate residents in Ethiopia. Ann. Trop. Med. Parasitol. (2000) 94:269-278.
   PubMed Web of Science ®Google Scholar
• ANGARANO G, MAGGI P, DI BARI MA et al.: Giardiasis in HIV: a possible role in patients with severe immune deficiency. Eur. J. Epidemiol. (1997) 13:485-487.
   PubMed Web of Science ®Google Scholar
• NASH TE, OHL CA, THOMAS E, SUBRAMANIAN G, KEISER P, MOORE TA: Treatment of patients with refractory giardiasis. Clin. Infect. Dis. (2001) 33:22-28.
   PubMed Web of Science ®Google Scholar
• ARONSON NE, CHENEY C, RHOLL V, HADRO N: Biliary giardiasis in a HIV patient. J. Clin. Gastroenterol. (2001) 33:167-170.
   PubMed Web of Science ®Google Scholar
• MOREIRA ED Jr, NASSRI VB, SANTOS RS et al.: Association of Helicobacter pylori infection and giardiasis: results from a study of surrogate markers for fecal exposure among children. World J. Gastroenterol. (2005) 11:2759-2763.
   PubMed Web of Science ®Google Scholar
• WIDGREN S, PANCHET B, VOIROL M: Giardia lamblia gastritis. A case report. Rev. Med. Suisse Romande (2001) 121:153-156.
   PubMedGoogle Scholar
• BORAN M, CETIN S: Helicobacter pylori and Giardia lamblia infections in hemodialysis patients. Nephrol. Dial. Transplant. (1999) 14:1803-1804.
   PubMed Web of Science ®Google Scholar
• HEWAN-LOWE K, FURLONG B, SIMS M, SCHWARTZ DA: Coinfection with Giardia lamblia and Enterocytozoon bieneusi in a patient with acquired immunodeficiency syndrome and chronic diarrhea. Arch. Pathol. Lab. Med. (1997) 121:417-422.
   PubMed Web of Science ®Google Scholar
• KHATAMI SS, MUKUNDA B, RAVAKHAH K: Coinfection with Giardia lamblia and Clostridium difficile after use of ranitidine. Am. J. Med. Sci. (2004) 327:91-93.
   PubMed Web of Science ®Google Scholar
• CROUCH AA, SEOW WK, WHITMAN LM, THONG YH: Sensitivity in vitro of Giardia intestinalis to dyadic combinations of azithromycin, doxycycline, mefloquine, tinidazole and furazolidone. Trans. R. Soc. Trop. Med. Hyg. (1990) 84:246-248.
   PubMed Web of Science ®Google Scholar
• JIMENEZ-CARDOSO E, FLORES-LUNA A, PEREZ-URIZAR J: In vitro activity of two phenyl-carbamate derivatives, singly and in combination with albendazole against albendazole-resistant Giardia intestinalis. Acta Trop. (2004) 92:237-244.
   PubMed Web of Science ®Google Scholar
• SMITH PD, GILLIN FD, SPIRA WM, NASH TE: Chronic giardiasis: studies on drug sensitivity, toxin production and host immune response. Gastroenterology (1982) 83:797-803.
   PubMed Web of Science ®Google Scholar
• TAYLOR GD, WENMAN WM, TYRRELL DL: Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis. CMAJ (1987) 136:1179-1180.
   PubMed Web of Science ®Google Scholar
• POPOVIC OS, MILOVIC V: Propranolol and metronidazole for metronidazole-resistant giardiasis. J. Clin. Gastroenterol. (1990) 12:604-605.
   PubMed Web of Science ®Google Scholar
• CACOPARDO B, PATAMIA I, BONACCORSO V, DI PAOLA O, BONFORTE S, BRANCATI G: Eficacia sinergica dell'associazione albendazole-metronidazole nella giardiasi refrattaria a monoterapia con metronidazolo. Clin. Ter. (1995) 146:761-767.
   PubMedGoogle Scholar